Zoonotic diseases — infections that can pass between animals and humans — are a growing global health challenge, particularly in regions where people live in close contact with wildlife. Understanding these interactions...
The Helmholtz Association is launching a nationwide biomedical engineering initiative to accelerate technology development and transfer activities. Led by its established Health Centers, “Helmholtz Biomedical...
Phyton Biotech has successfully transferred the manufacturing process for the microbial production of Corallopyronin A (CorA). CorA is a novel anti-infective agent with the potential to address neglected tropical...
On February 5, 2026, the President of the Helmholtz Association, Prof. Martin Keller, visited the Helmholtz Centre for Infection Research (HZI) in Braunschweig. In an open and cordial atmosphere, Keller took part in a...
The German National Cohort (NAKO) contributes its scientific expertise to the National Decade of Post-Infectious Diseases initiated by the Federal Ministry of Research, Technology and Space (BMFTR). With two central...
With funding from the Lower Saxony Ministry of Science and Culture (MWK) and the Volkswagen Foundation, the Helmholtz Centre for Infection Research (HZI) in Braunschweig has launched the large-scale project HUMAN....
How Long COVID develops is still largely unknown. New molecular connections are revealed in a recent study led by the Centre for Individualised Infection Medicine (CiiM). Using their approach of examining different...
The Helmholtz Association is kicking off 2026 with new research initiatives on strategic future topics to bring technological breakthroughs into practical application more quickly. The Helmholtz initiatives “Biomedical...
For decades, tuberculosis (TB) has been one of the deadliest infectious diseases worldwide. Resistant strains of Mycobacterium tuberculosis are particularly problematic, as many established drugs are becoming...
